1.Expression and regulation of pituitary adenylate cyclase-activating polypeptide mRNA in pregnant rat corpus luteum.
Wei ZHAO ; Dan-Ling CHENG ; Hui-Li ZHENG ; Hui ZHU ; Jiang NI
Chinese Journal of Applied Physiology 2010;26(3):313-317
OBJECTIVETo investigate the expression changes and regulation of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in corpus luteum during pregnancy.
METHODSPregnant rats' ovaries were collected at different time points. The techniques of RT-PCR and in situ hybridization were used to observe expression changes of PACAP mRNA in rat ovaries during pregnancy. To further explore the regulation mechanism of PACAP mRNA expression in corpus luteum, luteal cells were cultured in vitro. Immature (25 - 28 days old) female Sprague-Dawley rats were injected subcutaneously with 50IU pregnant mare serum gonadotrophin (PMSG), and 25IU human chorionic gonadotrophin (hCG) 48 h later, to induce follicular development and luteum formation. On day 6 after hCG administration (the day of hCG administration was the first day), the rats were killed by guillotine and the ovarian luteal cells were collected. After incubation for 24 h, luteal cells were administration with various factors for 24 h. And then expression changes of PACAP mRNA in luteal cells after administration with different factors were detected by RT-PCR, and radioimmunoassay was used to analyze progesterone levels.
RESULTSWith the development of pregnancy, the expression of PACAP mRNA increased gradually, reached the peak at pregnancy 19 d, and then decreased. Compared with control group, platelet activating factor (PAF), forskolin and PMA could obviously stimulate PACAP mRNA expression in luteal cells which were cultured with corresponding factors for 24 h. At the same time, progesterone levels in culture media were also elevated.
CONCLUSIONPACAP, acting as a local ovary regulator, was closely related to the maintenance of medium-term and late pregnancy. PAF could directly stimulate PACAP mRNA expression in luteal cells, and protein kinase C (PKC) and protein kinase A (PKA) signal pathways could both participate in this process.
Animals ; Cells, Cultured ; Corpus Luteum ; metabolism ; Female ; Pituitary Adenylate Cyclase-Activating Polypeptide ; genetics ; metabolism ; Platelet Activating Factor ; metabolism ; Pregnancy ; RNA, Messenger ; genetics ; Rats ; Rats, Sprague-Dawley
3.DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Mi Kyung KIM ; In Ho LEE ; Ki Heon LEE ; Yoo Kyung LEE ; Kyeong A SO ; Sung Ran HONG ; Chang Sun HWANG ; Mee Kyung KEE ; Jee Eun RHEE ; Chun KANG ; Soo Young HUR ; Jong Sup PARK ; Tae Jin KIM
Journal of Gynecologic Oncology 2016;27(2):e14-
OBJECTIVE: DNA methylation has been shown to be a potential biomarker for early cancer detection. The aim of this study was to evaluate DNA methylation profiles according to liquid-based Pap (LBP) test results and to assess their diagnostic value in a Korean population. METHODS: A total of 205 patients with various Papanicolaou test results were enrolled to this study (negative, 26; atypical squamous cells of undetermined significance, 39; low grade squamous intraepithelial lesion, 44; high grade squamous intraepithelial lesion (HSIL), 48; and cancer, 48). DNA methylation analysis of four genes, ADCYAP1, PAX1, MAL, and CADM1, was performed on residual cervical cells from LBP samples using a quantitative bisulfite pyrosequencing method. To evaluate the diagnostic performance of the four methylated genes for cancer detection, receiver operating characteristic (ROC) curves were drawn. Sensitivities and specificities were also tested at cutoffs determined from the ROC curves. RESULTS: Cervical cancer cells showed dramatically increased methylation levels for the four genes analyzed. ADCYAP1 and PAX1 also trended toward elevated methylation levels in HSIL samples, although the levels were much lower than those in cancer cells. The sensitivities of methylated ADCYAP1, PAX1, MAL, and CADM1 for the detection of cancer were 79.2%, 75.0%, 70.8%, and 52.1%, and the specificities were 92.0%, 94.0%, 94.7%, and 94.0%, respectively. Methylated ADCYAP1 and PAX1 demonstrated relatively better discriminatory ability than did methylated MAL and CADM1 (area under the curves 0.911 and 0.916 vs. 0.854 and 0.756, respectively). CONCLUSION: DNA methylation status, especially in the ADCYAP1 and PAX1 genes, showed relatively good specificity, ranging from 90% to 94%. The possible additive and complementary roles of DNA methylation testing with respect to conventional cervical cancer screening programs will need to be validated in prospective population-based studies.
Alphapapillomavirus/genetics
;
*Atypical Squamous Cells of the Cervix/pathology/virology
;
Cell Adhesion Molecules/genetics
;
*DNA Methylation
;
Female
;
Genotype
;
Humans
;
Immunoglobulins/genetics
;
Myelin and Lymphocyte-Associated Proteolipid Proteins/genetics
;
Paired Box Transcription Factors/genetics
;
Papanicolaou Test
;
Pituitary Adenylate Cyclase-Activating Polypeptide/genetics
;
ROC Curve
;
Squamous Intraepithelial Lesions of the Cervix/*genetics/pathology/virology
;
Uterine Cervical Neoplasms/*genetics/pathology/virology
;
Vaginal Smears
4.Expression and characterization of VPAC2 in CHO cells.
Rong-Jie YU ; Yuan GAO ; Yun DAI ; Ngai-lik TAM ; Zhi-Hong ZENG ; Tian-Hong ZHOU ; An HONG
Chinese Journal of Biotechnology 2006;22(6):996-1001
VPAC2 is a co-receptor of pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) and mediates multiple bio-functions. In order to construct the CHO line expressing VPAC2 stably, pcDNA-VPAC2 was used to transfect CHO cells. The positive clones were selected by G418 and the clone VPAC2-CHO with high sensitivity to PACAP38 was picked out by its ability to promoting the concentration of cAMP. RT-PCR, Western blot and Immunofluorescenece assay were used to identify the express of VPACS. Binding competition with VPAC2 agonist and the bioactivity of mediating the ligand to promote the concentration of cAMP showed that VPAC2 was expressed effectively in VPAC2-CHO. The results of Scatchard analysis revealed that VAPC2-CHO expressed a receptor density of (1.1 +/- 0.2) pmol/mg protein, respectively, with Kd values of (0.55 +/- 0.10) nmol/L for PACAP38 used as a tracer. The construction of CHO cells expressing VPAC2 specially and functionally lays a foundation not only for the further research on the characters and functions of VPAC2 but also for the screening and characterization of novel agonists of antagonists for VPAC2.
Animals
;
Binding, Competitive
;
CHO Cells
;
Cell Membrane
;
drug effects
;
metabolism
;
Cricetinae
;
Cricetulus
;
Cyclic AMP
;
metabolism
;
Gene Expression
;
Genetic Vectors
;
genetics
;
Iodine Radioisotopes
;
chemistry
;
Pituitary Adenylate Cyclase-Activating Polypeptide
;
chemistry
;
metabolism
;
pharmacology
;
Receptors, Vasoactive Intestinal Peptide, Type II
;
agonists
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Reverse Transcriptase Polymerase Chain Reaction
;
Transfection